Skip to content
10-Q

Quarterly Report

Yubo International Biotech Ltd YBGJ

0001640334-23-002200

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 19, 2023 119.82M sh
Capex Q3 2023 · Sep 30, 2023 $0
Capex Q3 2023 · Sep 30, 2022 $0
Cash And Equivalents Q3 2023 · Sep 30, 2023 $5.3K
Stockholders Equity Q3 2023 · Sep 30, 2023 −$1.1M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$1.15M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$838.76K
Stockholders Equity Q3 2023 · Dec 31, 2022 −$565.37K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$658.14K
Stockholders Equity Q3 2023 · Jun 30, 2022 −$1.25M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$760.12K
Stockholders Equity Q3 2023 · Dec 31, 2021 −$131.2K
Current Liabilities Q3 2023 · Sep 30, 2023 $2.87M
Current Liabilities Q3 2023 · Dec 31, 2022 $2.52M
Total Liabilities Q3 2023 · Sep 30, 2023 $3M
Total Liabilities Q3 2023 · Dec 31, 2022 $2.91M
Current Assets Q3 2023 · Sep 30, 2023 $712.3K
Current Assets Q3 2023 · Dec 31, 2022 $750.01K
Total Assets Q3 2023 · Sep 30, 2023 $1.9M
Total Assets Q3 2023 · Dec 31, 2022 $2.35M
Operating Cash Flow Q3 2023 · Sep 30, 2022 $88.58K
Net Income Q3 2023 · Sep 30, 2022 −$238.1K
Net Income Q3 2023 · Sep 30, 2022 −$1.31M
Net Income Q3 2023 · Jun 30, 2022 −$491.56K
Net Income Q3 2023 · Mar 31, 2022 −$578.95K
Operating Income Q3 2023 · Sep 30, 2022 −$238.27K
Operating Income Q3 2023 · Sep 30, 2022 −$1.31M
Gross Profit Q3 2023 · Sep 30, 2022 $9.6K
Gross Profit Q3 2023 · Sep 30, 2022 $23.72K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $4.98K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $14.05K
Revenue Q3 2023 · Sep 30, 2022 $14.58K
Revenue Q3 2023 · Sep 30, 2022 $37.76K